Stephen R Grobmyer
Overview
Explore the profile of Stephen R Grobmyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
2470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu C, Grencewicz D, Chakravarthy K, Li L, Liepold R, Wolf M, et al.
bioRxiv
. 2024 Nov;
PMID: 39554133
Background: Breast cancer, the most common cancer type among women, was recently found to contain a specific tumor microbiome, but its impact on host biology remains unclear. CD8 tumor-infiltrating lymphocytes...
2.
Rawashdeh R, Pederson H, Iskanderian R, Khan F, Altrabulsi B, Ricci S, et al.
JCO Glob Oncol
. 2024 Nov;
10:e2400352.
PMID: 39541563
Purpose: Breast cancer among Emirati patients is characterized by early-onset disease and later stages at presentation. Little is known about the germline genetic variants that may contribute to these observations....
3.
Iskanderian R, Matalkah A, Abdoh A, Al Hashmi A, Jallad B, Geara F, et al.
Gulf J Oncolog
. 2024 Jan;
1(44):25-29.
PMID: 38205569
Introduction: Breast cancer is the most frequent cancer among Emirati women and is the second leading cause of death among women in the UAE. To date, published studies regarding breast...
4.
Guzzo H, Valente S, Schwarz G, ElSherif A, Grobmyer S, Cakmakoglu C, et al.
Breast Cancer Res Treat
. 2022 Oct;
196(3):657-664.
PMID: 36239840
Purpose: Immediate lymphatic reconstruction (ILR) at the time of axillary lymph node dissection (ALND) can reduce the incidence of lymphedema in patients with breast cancer. The oncologic safety of ILR...
5.
Cocco D, Shah C, Wei W, Wilkerson A, Grobmyer S, Al-Hilli Z
Br J Surg
. 2022 Sep;
109(12):1293-1299.
PMID: 36066266
Background: De-escalation of axillary surgery in breast cancer has progressively taken place when appropriate. Data supporting surgical de-escalation in patients with clinically node-positive (cN+) disease remains scarce. Here, survival among...
6.
Pederson H, ElSherif A, Allyn B, Grobmyer S
Surgery
. 2022 May;
172(2):494-499.
PMID: 35577611
Background: Historically, surgeons have provided subspecialty breast care. The development of a robust medical breast program in a large academic center staffed by trained primary care providers initially showed a...
7.
8.
Tzeng A, Sangwan N, Jia M, Liu C, Keslar K, Downs-Kelly E, et al.
Genome Med
. 2021 Apr;
13(1):60.
PMID: 33863341
Background: Currently, over half of breast cancer cases are unrelated to known risk factors, highlighting the importance of discovering other cancer-promoting factors. Since crosstalk between gut microbes and host immunity...
9.
Valente S, Tendulkar R, Cherian S, Shah C, Ross D, Lottich S, et al.
Ann Surg Oncol
. 2021 Jan;
28(5):2512-2521.
PMID: 33433786
Background: Intraoperative radiation therapy (IORT) has been investigated for patients with low-risk, early-stage breast cancer. The The North American experience was evaluated by TARGIT-R (retrospective) to provide outcomes for patients...
10.
Iskanderian R, Karmstaji A, Mohamed B, Alahmed S, Masri M, Choufani E, et al.
Gulf J Oncolog
. 2021 Jan;
1(34):7-12.
PMID: 33431356
Introduction: COVID-19 has become a serious hazard worldwide in a relatively short time. Scientific evidence supports that cancer patients infected with COVID-19 had a higher risk of developing severe complications....